David Shook - 09 Jun 2025 Form 3 Insider Report for Lyell Immunopharma, Inc. (LYEL)

Signature
/s/ Charles Newton, as Attorney-in-Fact
Issuer symbol
LYEL
Transactions as of
09 Jun 2025
Net transactions value
$0
Form type
3
Filing time
11 Jun 2025, 17:38:58 UTC
Previous filing
17 Jan 2025
Next filing
11 Feb 2026

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Shook David Chief Medical Officer C/O LYELL IMMUNOPHARMA, INC., 201 HASKINS WAY, SUITE 101, SOUTH SAN FRANCISCO /s/ Charles Newton, as Attorney-in-Fact 11 Jun 2025 0001959742

No securities are beneficially owned.